Cutler Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,900
Closed -$5K 5464
2022
Q1
$5K Sell
20,900
-45,000
-68% -$1.93M ﹤0.01% 4147
2021
Q4
$25K Buy
+65,900
New +$2.58M ﹤0.01% 2951
2021
Q2
Sell
-14,700
Closed -$7K 6152
2021
Q1
$7K Buy
14,700
+9,700
+194% +$303K ﹤0.01% 4124
2020
Q4
$1K Sell
5,000
-5,500
-52% -$141K ﹤0.01% 4500
2020
Q3
$1K Buy
+10,500
New +$153K ﹤0.01% 4405
2020
Q2
Sell
-400
Closed -$1K 4730
2020
Q1
$1K Buy
+400
New +$2.41K ﹤0.01% 3759
2018
Q1
Sell
-100
Closed -$1K 5004
2017
Q4
$1K Buy
+100
New +$2.22K ﹤0.01% 4525
2017
Q2
Sell
-3,800
Closed -$3K 6859
2017
Q1
$3K Buy
+3,800
New +$136K ﹤0.01% 5183

Other funds holding ACH

Cutler Group's ACH Position: Q2 2022 in Review

Cutler Group sold out of Accendra Health (ACH) in Q2 2022, closing a stake of 1,000 shares — an estimated $44K sold.

Cutler Group first reported a position in ACH in Q4 2015 and held it in 9 quarters. The position peaked at $246K in Q4 2015. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • Cutler Group reported no remaining Accendra Health position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 1,000 Accendra Health shares in Q2 2022, an estimated $44K.
  • Cutler Group first reported a position in Accendra Health in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Accendra Health position peaked at $246K in Q4 2015.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.